Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment basliginda one cikan gelisme: CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.